Beta Bionics (BBNX) Asset Utilization Ratio (2025 - 2026)
Beta Bionics' (BBNX) quarterly Asset Utilization Ratio came in at 0.35 in Q1 2026, up 21.59% year-on-year from 0.29 in Q1 2025, and up 14.41% quarter-over-quarter from 0.3 in Q4 2025.
Beta Bionics (BBNX) Asset Utilization Ratio (2025 - 2026) Analysis & Trends
Beta Bionics has disclosed Asset Utilization Ratio across 2 years of filings, most recently posting 0.35 for Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.35, up 21.59% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.35 (up 21.59% YoY), and the FY2025 annual result was 0.42, down 16.44% from the prior year.
- Asset Utilization Ratio came in at 0.35 for Q1 2026 at Beta Bionics, up from 0.3 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.35 in Q1 2026 to a low of 0.23 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.39 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.47 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.65 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.74 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.57 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 0.56 |
| 10 | Beta Bionics | 617.66 Mn | 587.36 Mn | 16.44 Mn | 0.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.35 |
| Dec 31, 2025 | 0.30 |
| Sep 30, 2025 | 0.27 |
| Jun 30, 2025 | 0.23 |
| Mar 31, 2025 | 0.29 |